Cas:143163-72-8 2-(Bromomethyl)-5-chloro-1,3-benzothiazole manufacturer & supplier

We serve Chemical Name:2-(Bromomethyl)-5-chloro-1,3-benzothiazole CAS:143163-72-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-(Bromomethyl)-5-chloro-1,3-benzothiazole

Chemical Name:2-(Bromomethyl)-5-chloro-1,3-benzothiazole
CAS.NO:143163-72-8
Synonyms:2-bromomethyl-5-chlorobenzothiazole
Molecular Formula:C8H5BrClNS
Molecular Weight:262.55400
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:41.13000
Exact Mass:260.90100
LogP:3.84460

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-bromomethyl-5-chlorobenzothiazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-bromomethyl-5-chlorobenzothiazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-bromomethyl-5-chlorobenzothiazole Use and application,2-bromomethyl-5-chlorobenzothiazole technical grade,usp/ep/jp grade.


Related News: Chung also said South Korean citizens who had visited the province in the past 14 days should voluntarily quarantine themselves at home for two weeks after they arrive back into the country. 2-(Bromomethyl)-5-chloro-1,3-benzothiazole manufacturer Additional results from the trial with data on another goal of extending survival is expected in 2020, AstraZeneca said. 2-(Bromomethyl)-5-chloro-1,3-benzothiazole supplier Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday. 2-(Bromomethyl)-5-chloro-1,3-benzothiazole vendor Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector. 2-(Bromomethyl)-5-chloro-1,3-benzothiazole factory Additional results from the trial with data on another goal of extending survival is expected in 2020, AstraZeneca said.